A New York federal judge took the rare step of terminating a case this week due to an attorney's repeated misuse of AI in drafting filings, while the FDA announced its intent to restrict GLP-1 active pharmaceutical ingredients (APIs) used in non-FDA-approved compounded drugs. Additionally, a new surgical procedure is helping cancer survivors give birth, and a concerning new attack chain is exploiting vulnerabilities in cloud environments.
District Judge Katherine Polk Failla ruled that extraordinary sanctions were warranted after attorney Steven Feldman repeatedly submitted filings containing fake citations, according to Ars Technica. One filing was noted for its "conspicuously florid prose." The FDA's actions, announced on February 6, 2026, aim to protect consumers from drugs whose quality, safety, or efficacy cannot be verified, as stated by the FDA Commissioner of Food and Drugs, Martin A. Makary, M.D., M.P.H. The FDA is also taking steps to combat misleading advertising.
In the medical field, an experimental surgical procedure is helping cancer survivors have babies. Surgeons are now stitching the uterus, ovaries, and fallopian tubes out of the way during cancer treatment, and then putting them back in place after treatment. A team in Switzerland shared news that a baby boy, Lucien, was born after his mother had the procedure, making him the fifth baby born after the surgery and the first in Europe, according to MIT Technology Review. Daniela Huber, the gyno-oncologist who performed the operation, confirmed this.
Meanwhile, a new attack chain, known as the identity and access management (IAM) pivot, is emerging as a significant threat. According to CrowdStrike Intelligence research published on January 29, a developer receiving a seemingly legitimate LinkedIn message with a coding assessment can unknowingly install a package that exfiltrates cloud credentials. Within minutes, an adversary can gain access to the cloud environment, as detailed by VentureBeat.
The cost of turning written business logic into code has dropped to near-zero, according to Marc Brooker, an engineer at Amazon Web Services (AWS), in his blog. However, the cost of integrating services and libraries remains a challenge.
Discussion
AI Experts & Community
Be the first to comment